BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3484963)

  • 1. Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women.
    Nilsson IM; Felding P; Lecander I; Lennér C; Astedt B
    Br J Haematol; 1986 Feb; 62(2):215-20. PubMed ID: 3484963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women.
    Häggroth L; Mattsson C; Felding P; Nilsson IM
    Thromb Res; 1986 Jun; 42(5):585-94. PubMed ID: 3087015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma.
    Lecander I; Astedt B
    Br J Haematol; 1986 Feb; 62(2):221-8. PubMed ID: 3484964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor (PAI-1) in plasma and platelets.
    Booth NA; Simpson AJ; Croll A; Bennett B; MacGregor IR
    Br J Haematol; 1988 Nov; 70(3):327-33. PubMed ID: 3264718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.
    Gilabert J; Estellés A; Aznar J; España F; Andrés C; Santos T; Vallés J
    Thromb Haemost; 1990 Jun; 63(3):361-6. PubMed ID: 2144918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta.
    Philips M; Juul AG; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1986 Apr; 55(2):213-7. PubMed ID: 2424117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.
    Declerck PJ; Alessi MC; Verstreken M; Kruithof EK; Juhan-Vague I; Collen D
    Blood; 1988 Jan; 71(1):220-5. PubMed ID: 3257145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
    Nakashima A; Kobayashi T; Terao T
    Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
    Sprengers ED; Akkerman JW; Jansen BG
    Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.
    Wright JG; Cooper P; Astedt B; Lecander I; Wilde JT; Preston FE; Greaves M
    Br J Haematol; 1988 Jun; 69(2):253-8. PubMed ID: 3134043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
    Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
    J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-activator inhibitors of plasminogen].
    Juhan-Vague I; Alessi MC; Aillaud MF
    Ann Biol Clin (Paris); 1987; 45(2):202-6. PubMed ID: 3113299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological relationship between plasminogen activator inhibitors from different sources.
    Urdén G; Chmielewska J; Carlsson T; Wiman B
    Thromb Haemost; 1987 Feb; 57(1):29-34. PubMed ID: 2438797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
    Sprengers ED
    Thromb Haemost; 1986 Feb; 55(1):74-7. PubMed ID: 3085268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
    Erickson LA; Ginsberg MH; Loskutoff DJ
    J Clin Invest; 1984 Oct; 74(4):1465-72. PubMed ID: 6434594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fast inhibitor of tissue plasminogen activator in plasma during pregnancy.
    Wiman B; Csemiczky G; Marsk L; Robbe H
    Thromb Haemost; 1984 Oct; 52(2):124-6. PubMed ID: 6441300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.